申请人:Gilead Sciences, Inc.
公开号:US20160083368A1
公开(公告)日:2016-03-24
Compounds of formula I:
or salts thereof are disclosed. Also disclosed are pharmaceutical compositions comprising a compound of formula I, processes for preparing compounds of formula I, intermediates useful for preparing compounds of formula I and therapeutic methods for treating a Retroviridae viral infection including an infection caused by the HIV virus.
本发明揭示了化学式I的化合物或其盐。本发明还揭示了包括化合物I的药物组合物,制备化合物I的方法,用于制备化合物I的中间体以及治疗Retroviridae病毒感染,包括HIV病毒感染的治疗方法。